Loading organizations...
Jacobs Investment Company, established in 2004, operates as an investment firm, with Mark Lanigan serving as a Co-Founder and Managing Director, holding a key leadership position. While its founding year and leadership are known, comprehensive details regarding its precise operational focus, specific investment strategies, or target asset classes are not publicly disclosed. The firm's headquarters location, its overarching business model, and the sectors it primarily engages with remain largely unstated in public records. Furthermore, information concerning the company's scale, including assets under management, funding rounds, or portfolio valuation, is not publicly accessible. Specific details about potential portfolio companies, lead investors, or customer relationships are also not publicly detailed, leaving many aspects of its operations undefined. Its business model centers on unknown.
Jacobs Investment Company has 3 tracked investments across 3 companies. The latest tracked deal is $12.5M Series C in MST Medical Surgery Technologies in July 2015.
| Date | Company | Round | Lead Investor(s) | Co-Investor(s) |
|---|---|---|---|---|
| Jul 1, 2015 | MST Medical Surgery Technologies | $12.5M Series C | Wang Junmin | Agate Medical Investments, OurCrowd, SCP Vitalife Partners, Triventures |
| Dec 19, 2014 | Nutrinia | $12.0M Series C | Jacobs Investment Company, OrbiMed, Pontifax | — |
| Aug 20, 2013 | DermTech | $5.6M Series B | Jacobs Investment Company | — |